Combination Approaches to Target PD-1 Signaling in Cancer is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI150597
NCI NIH HHS
Grant: R21 CA231277
NIAID NIH HHS
Grant: R01 AI125640
NCI NIH HHS
Grant: F30 CA271624
National Institutes of Health
Grant: 5R01AI125640-09
Novel mechanisms regulating PD-1 signaling and function
National Institutes of Health
Grant: 1R21CA231277-01A1
(PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade
National Institutes of Health
Grant: 5R01AI150597-04
PAG is a novel target in immunotherapy
FWCI
3.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals